THYROCARE TECHNOLOGIES
Back to Cashflow Statement
|
THYROCARE TECHNOLOGIES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-85 Cr | ₹-86 Cr | ₹-89 Cr | ₹-62 Cr | ₹-165 Cr |
What is the latest Cash Flow from Financing Activities ratio of THYROCARE TECHNOLOGIES ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-85 Cr |
Mar2023 | ₹-86 Cr |
Mar2022 | ₹-89 Cr |
Mar2021 | ₹-62 Cr |
Mar2020 | ₹-165 Cr |
How is Cash Flow from Financing Activities of THYROCARE TECHNOLOGIES Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-85 Cr | Negative | |
Mar2023 | ₹-86 Cr | Negative | |
Mar2022 | ₹-89 Cr | Negative | |
Mar2021 | ₹-62 Cr | Negative | |
Mar2020 | ₹-165 Cr | - |
Compare Cash Flow from Financing Activities of peers of THYROCARE TECHNOLOGIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
THYROCARE TECHNOLOGIES | ₹3,826.1 Cr | -7% | -15.3% | 22.4% | Stock Analytics | |
MAX HEALTHCARE INSTITUTE | ₹97,685.7 Cr | -6.3% | -2.4% | 13.8% | Stock Analytics | |
APOLLO HOSPITALS ENTERPRISE | ₹90,104.8 Cr | -7.4% | -8.2% | -5.6% | Stock Analytics | |
FORTIS HEALTHCARE | ₹45,520.2 Cr | -3.9% | -6.5% | 43.9% | Stock Analytics | |
GLOBAL HEALTH | ₹29,803.8 Cr | -1.6% | 8.8% | -14.9% | Stock Analytics | |
NARAYANA HRUDAYALAYA | ₹27,167.7 Cr | -4.5% | 2.1% | -6.2% | Stock Analytics |
THYROCARE TECHNOLOGIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
THYROCARE TECHNOLOGIES | -7% |
-15.3% |
22.4% |
SENSEX | -2.5% |
-1.4% |
6.1% |
You may also like the below Video Courses